Lovastatin in Treating Patients At High Risk of Melanoma

NCT00462280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Precancerous Condition
Stage 0 Melanoma
Stage I Melanoma
Stage II Melanoma

Interventions

DRUG: lovastatin
OTHER: placebo
PROCEDURE: biopsy
PROCEDURE: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)